Martin Auster

Stock Analyst at Raymond James

(2.54)
# 2,386
Out of 5,044 analysts
55
Total ratings
53.66%
Success rate
12.72%
Average return

Stocks Rated by Martin Auster

Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $69.65
Upside: -
BridgeBio Pharma
Oct 21, 2025
Maintains: Outperform
Price Target: $56$59
Current: $66.62
Upside: -11.44%
Disc Medicine
Oct 17, 2025
Maintains: Strong Buy
Price Target: $89$108
Current: $85.00
Upside: +27.06%
Ascendis Pharma
Oct 17, 2025
Initiates: Strong Buy
Price Target: $271
Current: $205.71
Upside: +31.74%
Dyne Therapeutics
Aug 25, 2025
Upgrades: Strong Buy
Price Target: $31$35
Current: $23.63
Upside: +48.12%
Alnylam Pharmaceuticals
Aug 1, 2025
Reiterates: Outperform
Price Target: $370$424
Current: $481.59
Upside: -11.96%
BioMarin Pharmaceutical
Sep 18, 2023
Initiates: Buy
Price Target: $120
Current: $51.86
Upside: +131.39%
Ultragenyx Pharmaceutical
Mar 16, 2022
Upgrades: Outperform
Price Target: $99$105
Current: $34.59
Upside: +203.56%
Fulcrum Therapeutics
Mar 22, 2021
Initiates: Outperform
Price Target: $26
Current: $9.36
Upside: +177.78%
Solid Biosciences
Mar 16, 2021
Maintains: Neutral
Price Target: $105$120
Current: $5.49
Upside: +2,085.79%
Maintains: Outperform
Price Target: $725$300
Current: $7.47
Upside: +3,916.06%
Maintains: Outperform
Price Target: $49$58
Current: $31.41
Upside: +84.65%
Maintains: Outperform
Price Target: $169$196
Current: $455.32
Upside: -56.95%
Maintains: Outperform
Price Target: $62$98
Current: $1.59
Upside: +6,063.52%
Maintains: Outperform
Price Target: $50$60
Current: $166.95
Upside: -64.06%
Initiates: Outperform
Price Target: $65
Current: $29.27
Upside: +122.07%
Maintains: Neutral
Price Target: $156$73
Current: $23.45
Upside: +211.30%
Downgrades: Underperform
Price Target: n/a
Current: $5.38
Upside: -
Maintains: Outperform
Price Target: $76$78
Current: $70.59
Upside: +10.50%
Upgrades: Outperform
Price Target: n/a
Current: $2.87
Upside: -
Maintains: Outperform
Price Target: $27$43
Current: $10.26
Upside: +319.10%
Maintains: Neutral
Price Target: $19$21
Current: $13.12
Upside: +60.06%
Maintains: Neutral
Price Target: $14$16
Current: $36.12
Upside: -55.70%